All In Biotech

Drug Trial Radar · NCT04629703

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Last checked: Nov 20, 2026Latest source record: Aug 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 280 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

280

Actual

Start

Mar 25, 2021

Primary completion

Sep 5, 2022

Study completion Sep 5, 2022

Sponsor

Lead sponsor
Rigel PharmaceuticalsIndustry
Sponsor type
Industry
First posted
Nov 16, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is a double-blind, randomized, placebo-controlled, multi-center, Phase 3 study to evaluate the efficacy and safety of fostamatinib in COVID-19 subjects.

Conditions

  • Covid19
  • SARS (Severe Acute Respiratory Syndrome)
  • SARS Pneumonia
  • SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere
  • Pneumonia
  • Pneumonia, Viral

Interventions

  • FostamatinibDrug

    Fostamatinib (150 mg twice daily) for 14 days and Standard of Care

  • PlaceboDrug

    Placebo (twice daily) for 14 days and Standard of Care

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of days on oxygen from randomization on Day 1 to Day 29Time frame: 29 days

Locations

47 sites in 4 countries. Site status is shown where the registry gives one.

  • University of California Irvine

    Orange, California

  • George Washington University Hospital

    Washington D.C., District of Columbia

  • Alternative Research Associates, LLC

    Hialeah, Florida

  • Alternative Research Associates, LLC

    Miami, Florida

  • Loyola University Medical School

    Maywood, Illinois

  • Harvard Medical School- Bringham and Women's Hospital

    Boston, Massachusetts

  • Henry Ford

    Detroit, Michigan

  • Ascension Medical Group- St. John Clinic Infectious Disease

    Tulsa, Oklahoma

  • Houston Methodist Research Institute

    Houston, Texas

  • Hospital de Alta Complejidad Cuenta Alta

    Buenos Aires, Argentina

  • Hospital Del Bicentenario - Dr. Luis Federico Leloir

    Buenos Aires, Argentina

  • Clinica Zabala

    Buenos Aires, Argentina

  • Clinica Adventista Belgrano

    Buenos Aires, Argentina

  • Clinica Monte Grande

    Buenos Aires, Argentina

  • Hospital de Infecciosas Dr.Francisco Javier Muñiz

    Buenos Aires, Argentina

  • Sanatorio Guemes

    Buenos Aires, Argentina

  • Sanatorio Sagrado Corazon

    Buenos Aires, Argentina

  • Hospital San Roque

    Córdoba, Argentina

  • Sanatorio Mayo Privado

    Córdoba, Argentina

  • Corporacion Medica de General San Martin

    San Martín, Buenos Aires, Argentina

  • Clinica Chutro

    Córdoba, CP, Argentina

  • Hospital Lencinas

    Godoy Cruz, Mendoza Province, Argentina

  • Hospital das Clínicas da Universidade Federal de Goiás (HC/UFG)

    Goiânia, Goiás, Brazil

  • Hospital Luxenburgo-Associação Mário Penna

    Belo Horizonte, Minas Gerais, Brazil

  • Hosp. Angelina Caron

    Campina Grande do Sul, Paraná, Brazil

  • Hospital Universitario de Maringa

    Maringá, Paraná, Brazil

  • Irmandade da Santa Casa de Misericórdia de Porto Alegre - ISCMPA

    Porto Alegre, Rio Grande do Sul, Brazil

  • Hospital des clinicas de porto alegre - Centro de pequisas clinicas

    Porto Alegre, Rio Grande do Sul, Brazil

  • Complexo de Prevenção, Diagnóstico, Terapia e Reabilitação Respiratória LTDA

    Blumenau, Santa Catarina, Brazil

  • Hospital Alemão Oswaldo Cruz (HAOC)

    Bela Vista, São Paulo, Brazil

  • Hospital Universitário São Francisco na Providência de Deus

    Bragança Paulista, São Paulo, Brazil

  • Pontificia Universidade Catolica de Campinas (PUC-CAMP) - Hospital e Maternidade Celso Pierro (HMCP)

    Campinas, São Paulo, Brazil

  • Hospital Bandeirantes (LeForte)

    Liberdade, São Paulo, Brazil

  • Fundação Faculdade Reg. de Med de SJRP

    São José do Rio Preto, São Paulo, Brazil

  • Clinica de Alergia Martti Antila S/S Ltda

    Sorocaba, São Paulo, Brazil

  • Hospital Cardiologica Aguascalientes

    Aguascalientes, Mexico

  • Icaro Investigaciones en Medicina

    Chihuahua City, Mexico

  • Nuevo Hospital Civil de Guadalajara

    Guadalajara, Mexico

  • Centro Medico Issemym Toluca

    Metepec, Mexico

  • Hospital Ángeles Roma

    México, Mexico

Showing 40 of 47 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.